Pfizer CEO Bourla asks employees to join the scrum for D.C. drug-pricing fight

Pfizer may be fighting the pandemic with its COVID-19 vaccine, but it's waging another sort of battle in Washington, D.C.

Pfizer CEO Albert Bourla, Ph.D., has sent a three-minute video message to employees asking them to resist government drug-pricing negotiations, Politico first reported. Lawmakers are pushing measures that would allow Medicare to negotiate some drug prices, a measure the industry has long resisted, as one way to help pay for President Joe Biden's proposed $3.5 trillion spending package.